P-849 The economic implications of adding granulocyte-colony stimulating factor (G-CSF) andlor antibiotics as secondary prophylaxis to small cell lung cancer (SCLC) patients at risk of febrile neutropenia (FN): A Markov model based on the clinical results of a prospective randomised phase III study

✍ Scribed by Timmer-Bonte, J.; Termeer, E.; Adang, E.; Tjan-Heijnen, V.

• Book ID: 122797114
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 144 KB
• Volume: 49
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/S0169-5002(05)81342-X